5-Fluoro-2-Oxindole CAS 56341-41-4 Ịdị ọcha>99.0% (LCMS) Sunitinib Malate Intermediate Factory egosipụtara

5-Fluoro-2-Oxindole CAS 56341-41-4 Ịdị ọcha>99.0% (LCMS) Ụlọ ọrụ etiti Sunitinib Malate

Nkọwa dị mkpirikpi:

Aha Chemical: 5-Fluoro-2-Oxindole

Nọmba: 56341-41-4

Ọdị ọcha:>99.0% (LCMS)

Ọdịdị: Light Yellow Crystalline Powder

Ọkara nke Sunitinib Malate (CAS: 341031-54-7)

Ogo dị elu, mmepụta azụmahịa

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata 5-Fluoro-2-Oxindole (CAS: 56341-41-4) nwere àgwà dị elu, mmepụta azụmahịa.Nabata ịtụ.

Njirimara kemịkalụ:

Aha Chemical	5-Fluoro-2-Oxindole
Ụdị okwu	5-Fluorooxindole;5-Fluoro-2-indolinone;5-Fluoroindolin-2-otu;5-Fluoro-1,3-Dihydro-indol-2-otu
Nọmba CAS	56341-41-4
Nọmba CAT	RF-PI1543
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C8H6FNO
Ibu molekụla	151.14
Njupụta	1.311±0.06 g/cm3
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ntụ ntụ kristal na-acha odo odo
1 H NMR Spectrum	Nkwekọrịta na Ọdịdị
LCMS	Nkwekọrịta na Ọdịdị
Ụzọ ịdị ọcha / nyocha	> 99.0% (LCMS)
Ebe Na-agbaze	143.0 ~ 147.0 ℃
Ọnwụ na ihicha	<0.50%
Mgbakọta adịghị ọcha	<1.00%
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ndị n'etiti ọgwụ;Sunitinib Malate Intermediate

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.

Uru:

Ajụjụ:

Ngwa:

5-Fluoro-2-Oxindole (CAS: 56341-41-4) na-ejikarị eme ihe na ụlọ ọrụ ọgwụ dị ka onye na-ahụ maka ọgwụ.5-Fluoro-2-Oxindole bụ etiti na njikọ nke Sunitinib Malate (CAS: 341031-54-7).Sunitinib Malate bụ ụdị akwụkwọ akụkọ eji egbu egbu egbu egbu egbu egbu ma bụrụ nke tyrosine kinase inhibitor ezubere iche nwere aha azụmaahịa ya bụ “Suntent”.Ụlọ ọrụ Pfizer mepụtara ya nke ọma ma nwee mmetụta mgbochi tumor abụọ.Ọzọkwa, ọ bụ naanị ọgwụgwọ ọgwụgwọ nke nwere ike ịgafe oge ndụ afọ 2 nke ọrịa kansa akụrụ dị elu ma na-arụ ọrụ dị mkpa na ngalaba nke carcinoma na mpaghara eriri afọ stromal tumor therapeutic.Ọ banyere n'ahịa na February 2006 na United States.Ọgwụ a bụ ọgwụ mbụ na-egbochi ọrịa kansa nke US FDA kwadoro ma nwee ike ịgwọ ọrịa abụọ n'otu oge.